Michelle Dawson posts

Post published on Twitter/X on 3 Dec 2012 11:28

Twitter/X Clinical trial clinicaltrials.gov External link integrated into the post Autism terms

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Hadassah Medical Organization (2014). TSO in Pediatric Autistic Spectrum Disorders. ClinicalTrials.gov. Hadassah Medical Organization.

Publication date
2014
Identifier
NCT01734941
Authors
Hadassah Medical Organization
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Hadassah Medical Organization
Metadata source
clinicaltrials.gov

Abstract

The primary objective of this study is to evaluate and compare the safety and efficacy of Trichuris suis ova (TSO) therapy (versus placebo) in pediatric patients with autism. Evaluation of the safety and tolerability of treatment with TSO in the target population across the dose range being tested is considered a primary objective, while the primary efficacy objective will be assessed via the change from baseline in the Aberrant Behavior Checklist (ABC) subscale scores. Dose response will be considered a primary objective as well. Secondary assessments of efficacy will be assessed via: • The change from baseline in the Clinical Global Impression scale (CGI-I)